SCHEDULE 13D

Company

Opus Genetics, Inc.

Filed

January 21, 2005

Accession Number

0000893838-05-000015

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →